Oncology and Breast Cancer Research

At RKH Klinken Ludwigsburg-Bietigheim gGmbH, a major share of clinical research focuses on neoplasms, especially breast cancer and related advanced or high-risk disease. Studies are exploring new treatment combinations and personalized approaches to improve survival, delay recurrence, and refine care after surgery or standard therapy.

  • Advanced and early-stage breast cancer, including triple-negative and hormone receptor-positive disease
  • Testing novel cancer therapies to improve disease-free survival, progression-free survival, and long-term outcomes
  • Personalized treatment strategies for patients with residual disease or molecular markers linked to relapse

The site’s oncology work also includes efforts to improve treatment effectiveness while reducing the risk of cancer recurrence in patients receiving standard and newer targeted therapies.

Gastrointestinal and Hepatobiliary Cancer Studies

Research in digestive system diseases covers several cancers of the stomach, colon, rectum, and bile ducts. These trials are designed to evaluate better treatment options before or after surgery, as well as new targeted and immunotherapy-based approaches for difficult-to-treat gastrointestinal tumors.

  • Colorectal cancer, including metastatic and resectable disease
  • Gastric cancer, gastroesophageal junction cancer, and esophagogastric adenocarcinoma
  • Cholangiocarcinoma, including intrahepatic and hilar forms

These studies aim to improve survival, support more effective use of surgery and systemic therapy, and test whether newer combinations can control disease more effectively than current standards.

Gynecologic Oncology and Endometrial Cancer

The site also has an active program in gynecologic cancers, with trials focused on endometrial cancer, ovarian cancer, and related tumors. The research is centered on improving outcomes for patients with newly diagnosed, high-risk, or advanced disease through more tailored post-surgical and first-line treatment strategies.

  • Endometrial cancer, including molecularly defined high-risk groups
  • Ovarian cancer, fallopian tube cancer, and peritoneal cancer
  • Evaluating therapies intended to extend progression-free survival and reduce recurrence

These trials are helping clarify how best to combine established treatments with newer targeted or immune-based options for women facing advanced gynecologic malignancies.

Lung Cancer and Thoracic Oncology

Clinical trials in respiratory tract diseases and thoracic cancer are examining treatment options for non-small cell lung cancer, including resectable, unresectable, and metastatic disease. The goal is to improve control of the cancer while making treatment more effective and, in some cases, more tolerable for patients who cannot receive standard chemotherapy.

  • Non-small cell lung cancer, including advanced and surgically treatable forms
  • Lung adenocarcinoma with specific biological features
  • Testing combinations of immunotherapy, chemotherapy, and radiotherapy to improve outcomes

This area reflects a strong interest in refining thoracic cancer care through better treatment selection and more effective use of immune-based therapies.

Neurology, Stroke, and Supportive Care Research

Beyond cancer, the site conducts studies in nervous system diseases and acute neurological injury. These trials are assessing treatments for ischemic stroke, traumatic brain injury, and chemotherapy-induced polyneuropathy, with the aim of improving recovery, symptom control, and quality of life.

  • Acute ischemic stroke and recovery after endovascular treatment
  • Subacute traumatic brain injury and neurological support
  • Preventing or reducing chemotherapy-induced nerve damage in patients receiving cancer treatment

These projects show that the site’s research extends into supportive and neurologic care, not only disease treatment, with a focus on better outcomes for patients during and after therapy.